Selution Slr Pta
Payments companies reported to CMS as associated with Selution Slr Pta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Selution Slr Pta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Selution Slr Pta
These are the largest totals companies reported as associated with Selution Slr Pta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Aloke Finn | Baltimore, MD | Interventional Cardiology | $47,880.27 |
| Jimmy Kerrigan | Nashville, TN | Interventional Cardiology | $22,900.26 |
| Sameh Sayfo | Plano, TX | Interventional Cardiology | $22,391.48 |
| Brian Kolski | Orange, CA | Interventional Cardiology | $22,127.02 |
| Margaret Mcentegart | New York, NY | Interventional Cardiology | $18,263.13 |
| Matthew Price | La Jolla, CA | Interventional Cardiology | $12,635.28 |
| Hayder Hashim | Washington, DC | Cardiovascular Disease | $12,550.00 |
| Eric Secemsky | Boston, MA | Interventional Cardiology | $12,303.86 |
| Rhian Davies | York, PA | Cardiovascular Disease | $12,094.08 |
| Hannah Chaudry | Lebanon, NH | Interventional Cardiology | $10,594.11 |
Prescribed Selution Slr Pta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.